Deal Ends TodayΒ·Save 35% annual plan
Ranked & comparedReviewed July 2026

Top Apps to Track Alcohol Consumption

App guide

Ranked & compared

Sunnyside is the best app for mindful-drinking moderation (SMS coaching, calorie and money tracking); Reframe adds neuroscience-based curriculum for habit change; I Am Sober works for full abstinence β€” none have a free tier after their trial, and none are appropriate substitutes for clinical alcohol use disorder treatment.

Alcohol tracking apps fall into two categories: moderation tools like Sunnyside and Reframe, and sobriety trackers like I Am Sober. The right choice depends entirely on your goal. For GLP-1 users, tracking alcohol is particularly important because drinks add empty calories to an already limited intake budget, can worsen nausea, and may affect blood sugar when combined with certain medications. This review compares the top three apps honestly, including their real costs and limitations.

This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.

Why track it

What you're actually tracking

Alcohol tracking apps divide into two camps: moderation tools (Sunnyside, Reframe) and sobriety trackers (I Am Sober). The right category depends on your goal. For GLP-1 users, alcohol is particularly relevant because it adds empty calories in an already limited intake budget, worsens nausea, and can cause hypoglycemia if the medication is combined with certain other drugs. None of these apps is a clinical alcohol use disorder treatment.

Our method

How we evaluated them

Evaluated on: whether the app supports moderation vs. abstinence goals; coaching quality; calorie and drink-count tracking; price transparency (noting third-party review sources where official pricing was not published); and specific relevance to GLP-1 users managing empty calories and GI effects.

Ranked & compared

The apps, side by side

No single app wins for everyone β€” each card calls out who it's genuinely best for, so you can pick on fit, not hype.

  1. Sunnyside

    $12/mo, $29/quarter, or $99/yr (14–15 day trial); premium coaching $298/yriOS / Android

    Best for: Mindful-drinking moderation with SMS coaching

    • Easy text-based tracking shows calories and money saved
    • Structured moderation goals without abstinence requirement
    • No free tier after trial
    • Not appropriate for alcohol use disorder treatment
  2. Reframe

    7-day trial / App Store tiers from $13.99/mo up to ~$119.99/yriOS / Android

    Best for: Neuroscience-based alcohol reduction with structured education

    • Daily curriculum covering neuroscience of drinking
    • Craving toolkit and peer community
    • Pricier and more intensive than a simple drink counter
  3. I Am Sober

    Free / Sober Plus about $119.88/yr (often discounted to $39.99)iOS / Android

    Best for: Sobriety-focused tracking with daily pledges and milestones

    • Free day-counter, milestone tracking, and community feed
    • Not designed for moderation, only abstinence
    • No coaching component

Why Alcohol Tracking Matters More on GLP-1 Medications

Alcohol on a GLP-1 medication isn't just about empty calories β€” it's a triple problem that affects your nutrition, your side effects, and potentially your blood sugar. When your total daily intake drops to 1,200–1,600 calories on semaglutide or tirzepatide, every drink competes directly with the protein and fiber your body needs to preserve muscle and maintain digestive health.

GLP-1 receptor agonists slow gastric emptying, which is part of how they work β€” but alcohol can amplify the nausea, reflux, and bloating that are already common side effects, especially in the first few months. Many users report that even one drink hits harder and feels worse than it did before starting the medication.

There's also a blood sugar consideration. GLP-1 drugs themselves carry a low risk of hypoglycemia when used alone, but if you're also taking insulin or a sulfonylurea, alcohol can increase that risk. Alcohol temporarily impairs the liver's ability to release stored glucose, which can cause blood sugar to drop hours after drinking β€” a risk that's easy to miss if you're not tracking.

Interestingly, emerging clinical evidence suggests GLP-1 medications may actually reduce alcohol cravings through their effects on dopamine reward pathways in the brain. A 2023 analysis of semaglutide users on social media found a significant number reporting reduced desire to drink. This isn't yet an approved use, but it means the medication itself might make tracking and reducing alcohol easier than it would be otherwise.

Bottom line

Alcohol on GLP-1 is a triple problem β€” it competes with protein calories, worsens nausea, and can affect blood sugar. Tracking drinks keeps the impact visible rather than estimated.

Sunnyside vs. Reframe vs. I Am Sober: The Honest Comparison

These three apps serve fundamentally different goals, and picking the wrong one means you'll probably stop using it within a week. The first decision is whether you want to moderate or quit entirely.

Sunnyside is built for moderation. You set a weekly drink target, log each drink via a quick text message, and receive SMS-based coaching that nudges you toward your goal without demanding abstinence. The app calculates calories and money saved compared to your baseline, which makes the trade-off concrete. It's the lightest-touch option and the best fit for someone who wants to cut back from, say, 14 drinks a week to 8.

Reframe takes a more educational approach. It delivers a structured daily curriculum covering the neuroscience of habit formation, why cravings happen, and how to rewire drinking triggers. There's a craving toolkit with exercises you can use in the moment, plus a peer community for accountability. Reframe can support either moderation or abstinence, but it asks for more time and engagement than Sunnyside β€” you're signing up for a behavior-change course, not just a tracker.

I Am Sober is explicitly for abstinence. It gives you a day counter, a daily pledge to stay sober, milestone celebrations, and a community feed of people at similar stages. The free tier is genuinely functional, which is rare in this category. But if your goal is to drink less rather than stop completely, I Am Sober's all-or-nothing framing will feel misaligned.

On pricing: none of these apps offers a permanent free tier after the trial period. Sunnyside costs $12/month or $99/year after a 14–15 day trial. Reframe's pricing varies by App Store tier but starts around $13.99/month. I Am Sober has a free basic tier, but the full feature set (Sober Plus) runs about $119.88/year, often discounted to $39.99. If you're budget-conscious, I Am Sober's free version is the only genuinely no-cost option.

Bottom line

Sunnyside is designed for drinkers who want to cut back, not quit entirely; Reframe works for behavior-change learners; I Am Sober is for people who have decided on full abstinence.

How Alcohol Calories Add Up When Your Total Intake Is Already Low

The calorie math on GLP-1 medications is unforgiving. When semaglutide or tirzepatide reduces your appetite to the point where you're eating 1,200–1,500 calories a day, two drinks can consume 15–20% of that budget β€” and those calories come with zero protein, zero fiber, and minimal micronutrients.

A standard 5-ounce glass of red or white wine contains roughly 125 calories. A 12-ounce regular beer is about 150 calories. A 1.5-ounce shot of spirits is 97 calories β€” but that's before mixers, which can add another 100–200 calories in a typical cocktail. A restaurant margarita can easily land between 170 and 280 calories. Two of those, and you've spent 400–500 calories on alcohol alone.

On a 1,400-calorie GLP-1 diet, 400 calories from alcohol displaces what could have been 30–40 grams of protein β€” roughly a full chicken breast and a cup of Greek yogurt. Over weeks and months, that protein deficit compounds, contributing to the muscle loss that's already a risk during rapid weight loss. It's not that you can never drink; it's that the trade-off is steeper than most people realize until they see the numbers.

This is where Sunnyside's calorie-tracking feature earns its place. The app shows you, in real time, how many calories your logged drinks represent and how much money you've saved by skipping them. That dual feedback β€” health and financial β€” makes the abstract cost of drinking feel tangible in a way that generic calorie apps don't.

Bottom line

Two standard drinks on a GLP-1-reduced diet can displace a full meal's worth of protein β€” the trade-off becomes concrete when you see it in an app.

The GLP-1–Alcohol Interaction: What the Research Says

The relationship between GLP-1 receptor agonists and alcohol is an active area of research, and the early signals are intriguing. Multiple studies and a growing body of anecdotal reports suggest that semaglutide and tirzepatide may reduce alcohol cravings and consumption through their effects on the brain's reward system.

GLP-1 receptors exist in areas of the brain involved in dopamine signaling and reward processing β€” the same pathways implicated in addictive behaviors. Animal studies have shown that GLP-1 agonists reduce alcohol intake in rodents, and human observational data points in the same direction. A 2023 analysis of social media posts by semaglutide users found that a meaningful subset reported spontaneously drinking less, with some describing a near-total loss of interest in alcohol.

This is promising, but it's not established enough to rely on clinically. Reduced craving doesn't mean alcohol is safe to ignore. The medication's effects on gastric emptying can make alcohol absorption unpredictable β€” some users report feeling intoxicated faster or experiencing worse hangovers. And if you're taking other blood sugar–lowering medications, the hypoglycemia risk remains real.

The practical takeaway: if you notice you're craving alcohol less on a GLP-1, that's a useful tailwind for cutting back, but it doesn't replace tracking. Use the reduced desire as an opportunity to establish lower baseline drinking habits, not as a reason to stop paying attention. And if you drink regularly, mention it to your prescriber β€” they need the full picture to manage your medication safely.

Bottom line

Early research suggests GLP-1 drugs may blunt alcohol reward, but this is not established enough to rely on β€” don't use reduced cravings as a reason to skip tracking.

Setting a Realistic Drink Limit and Tracking It

The CDC defines moderate drinking as up to one drink per day for women and up to two for men β€” but those are ceilings, not targets, and on a GLP-1 medication you may find that even one drink feels like more than enough. A standard drink contains 14 grams of pure alcohol, which translates to 5 ounces of wine, 12 ounces of regular beer, or 1.5 ounces of distilled spirits.

The problem is that most poured drinks aren't standard. A generous home pour of wine can easily be 8–10 ounces. A craft beer might be 7% alcohol by volume instead of the standard 5%. A restaurant cocktail often contains 2–3 ounces of spirits plus liqueurs. Without measuring or logging, most people undercount by 30–50%.

Sunnyside makes this easier by letting you set a weekly drink target and log each drink with a quick text. The app adjusts your daily allowance based on your weekly goal and shows you a running tally. If you prefer a general calorie tracker, MyFitnessPal and Lose It both have extensive alcohol databases β€” but they won't give you the behavioral coaching or weekly goal structure that a dedicated alcohol app provides.

If you're just starting to track, begin with a baseline week where you log honestly without trying to change anything. Most people are surprised by the total. From there, set a realistic reduction β€” cutting by 25–30% is more sustainable than aiming for zero overnight. The apps work best when the goal feels achievable.

Bottom line

One standard drink is 5 oz wine, 12 oz regular beer, or 1.5 oz spirits β€” many cocktails contain 2–3 standard drinks, which most people undercount without an app.

The honest part

What most pages leave out

Sunnyside's pricing comes from a Healthline review rather than an official Sunnyside pricing page β€” verify in-app before subscribing. None of these apps are alcohol use disorder treatments; if alcohol use is clinically significant, a prescriber or addiction specialist referral is appropriate. Competitors rarely make this boundary explicit.

We flag this so you can make an informed choice β€” not to scare you off.

❓Frequently Asked Questions

Sunnyside is the best choice for moderation goals, offering SMS-based coaching plus calorie and money-savings tracking. I Am Sober is the best free option for abstinence tracking with a day counter and community support. Reframe is ideal if you want a structured neuroscience-based curriculum alongside drink tracking.

Possibly. GLP-1 drugs slow gastric emptying, which can affect how quickly alcohol is absorbed. Some users report feeling intoxicated faster or experiencing stronger effects from the same amount of alcohol they consumed before starting the medication.

Early evidence suggests GLP-1 receptor agonists may reduce alcohol cravings by affecting dopamine reward pathways in the brain. Observational data and animal studies are promising, but this effect is not yet established enough to rely on clinically as a treatment for alcohol use.

A standard 5-ounce glass of wine contains roughly 125 calories. A 12-ounce regular beer is about 150 calories. Hard liquor (1.5 ounces) is approximately 97 calories before mixers, which can add another 100–200 calories depending on what's added.

Sunnyside offers a 14–15 day free trial. After the trial, it costs $12 per month, $29 per quarter, or $99 per year. There is no permanent free tier, and premium coaching is available for $298 per year.

Moderate alcohol consumption is not specifically contraindicated for most GLP-1 users, but it can worsen nausea and other GI side effects, displace protein calories from your limited intake budget, and interact with blood sugar medications if you take them. Discuss your drinking habits with your prescriber.

I Am Sober has a genuine free tier that includes a sobriety day counter, milestone tracking, and a community feed. The paid Sober Plus tier costs about $119.88 per year but is frequently discounted to $39.99 and adds additional features.

Research published by Sunnyside suggests that combining drink tracking with moderation goals reduces weekly drink consumption for most users. Self-monitoring alone tends to improve awareness, and adding a specific target makes behavior change more likely, though the app's own data should be interpreted with appropriate caution.

Ranked & compared Β· from Curex

On a GLP-1, or thinking about one?

Eating well is the foundation. For some people, a GLP-1 medication is the tool that finally makes appetite manageable.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.

  • Compounded semaglutide from $49/mo, tirzepatide from $149/mo
  • Prescribed by licensed clinicians after an online visit
  • Delivered to your door β€” no in-person clinic required
See if a GLP-1 is right for youCompounded medications are not FDA-approved and the FDA has not evaluated their safety or efficacy. This is not a claim about Alcohol Consumption, which is not a Curex product. Always talk to a clinician before starting or changing any medication.

This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.

Weight care with Curex

Explore compounded GLP-1 options

Explore GLP-1 options

Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.

Ready to treat your allergies at the source?

Take the free allergy quiz to find out if immunotherapy is right for you and get started with personalized treatment today.

Take Free Allergy Quiz